PR NEWSWIRE

Previous Stories

BLUETTI Unveils Elite 300 in Australia: Most Compact 3kWh Portable Power Station

Dec 16 2025 - PR NewsWire

Elite 300 redefines the portability of 3kWh power stations for homes & the outdoors SYDNEY, Dec. 16, 2025 /PRNewswire/ —…


Miroma Project Factory: Powers Clinical-Grade App for One of Australia’s Largest Smoking Cessation Trials

Dec 16 2025 - PR NewsWire

SYDNEY, Dec. 16, 2025 /PRNewswire/ — Miroma Project Factory (MPF) has delivered a bespoke mobile solution for Screen2Quit, part of…


Miroma Project Factory: Powers Clinical-Grade App for One of Australia’s Largest Smoking Cessation Trials

Dec 16 2025 - PR NewsWire

SYDNEY, Dec. 16, 2025 /PRNewswire/ — Miroma Project Factory (MPF) has delivered a bespoke mobile solution for Screen2Quit, part of…


DMX-200 ACTION3 PHASE 3 TRIAL COMPLETES RECRUITMENT

Dec 15 2025 - PR NewsWire

Recruitment successfully completed in Dimerix’ ACTION3 Phase 3 clinical trial[1], which has recruited and dosed its target 286th adult patient…


DMX-200 ACTION3 PHASE 3 TRIAL COMPLETES RECRUITMENT

Dec 15 2025 - PR NewsWire

Recruitment successfully completed in Dimerix’ ACTION3 Phase 3 clinical trial[1], which has recruited and dosed its target 286th adult patient…


Rohit Markan Appointed Executive Vice President Asia Pacific For Continental’s Industrial Solutions Business

Dec 15 2025 - PR NewsWire

Appointment effective November 2025; reporting directly to Philip Nelles, head of Continental group sector ContiTech Brings extensive leadership experience from different…


Rohit Markan Appointed Executive Vice President Asia Pacific For Continental’s Industrial Solutions Business

Dec 15 2025 - PR NewsWire

Appointment effective November 2025; reporting directly to Philip Nelles, head of Continental group sector ContiTech Brings extensive leadership experience from different…


Patient Enrolment Completed in Phase 2 aGvHD Clinical Trial

Dec 15 2025 - PR NewsWire

Announcement Highlights: Patient enrolment has been completed in Cynata’s Phase 2 clinical trial of CYP-001 in acute graft versus host disease….


Patient Enrolment Completed in Phase 2 aGvHD Clinical Trial

Dec 15 2025 - PR NewsWire

Announcement Highlights: Patient enrolment has been completed in Cynata’s Phase 2 clinical trial of CYP-001 in acute graft versus host disease….


Avnet and AMD Showcase Scalable AI Solutions to Accelerate Australia’s Tech Leadership

Dec 15 2025 - PR NewsWire

SYDNEY, Dec. 15, 2025 /PRNewswire/ — Avnet and AMD have wrapped up the inaugural ‘AMD on Wheels’ national roadshow, bringing…


Analyse The Market From A Different Angle